Non-Invasive Biomarkers of NASH

The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH).  Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022. This browser does not support PDFs. Please download the PDF to view it: Download PDF.

STUDIES ARE ENROLLING NOW!

Opioid Use Disorder

We are conducting a research study to better understand and develop effective treatments for opioid use disorder. Your participation can make a significant difference in the fight against opioid addiction. If you are struggling with opioid use disorder, you may qualify for a paid clinical trial. Your privacy is a priority and all Information collected will be kept confidential. Learn more today.